DEA Seeks to Ensure Supply Chain Continuation and Patient Access Via Telemedicine During COVID-19 Pandemic

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Public Health

DEA Seeks to Ensure Supply Chain Continuation and Patient Access Via Telemedicine During COVID-19 Pandemic

Joan Flynn

April 5, 2020 at 11:48:08 ET

Any registered manufacturers, distributors or importers of controlled substances that are experiencing supply chain issues as a result of the ongoing coronavirus (COVID-19) pandemic should contact the Drug Enforcement Administration through the local field office or by email, DEA announced. The email address for contacting DEA is Natural.Disaster@usdoj.gov. The agency said it is n... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Seeks to Ensure Supply Chain Continuation and Patient Access Via Telemedicine During COVID-19 Pandemic

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT